Results 221 to 230 of about 310,119 (307)

Next-generation precision medicine for pain. [PDF]

Mol Psychiatry
Bhagar R, Le-Niculescu H, Corey SC, Gettelfinger AS, Schmitz M, Ebushi A, Matei E, Woods C, Mullen J, Kurian SM, Shekhar A, White FA, Niculescu AB.   +12 more
europepmc   +1 more source

What anabolic–androgenic steroids reveal about the limits of current harm reduction models

Addiction, EarlyView.
Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski, Jason M. Nagata, Suzanne Nielsen   +2 more
wiley   +1 more source

Associations between parental alcoholism and delinquent behaviours among youth: exploring serial and parallel mediation by posttraumatic stress disorder symptoms, anxiety symptoms and impulsivity. [PDF]

Eur J Psychotraumatol
Isingizwe BB, Niyonsenga J, Kanazayire C, Nduwamungu N, Ntete JM, Mutabaruka J.   +5 more
europepmc   +1 more source

High temporal resolution monitoring of illicit drug consumption across England via wastewater analysis

Addiction, EarlyView.
Abstract Aim To monitor community‐level consumption of 20 illicit drugs across urban areas of England using wastewater‐based epidemiology (WBE) surveillance at high temporal resolution. Design, setting, cases This study was conducted over a 12‐month period in 2022 sampling 24‐hour composite wastewater samples at 15 wastewater treatment plants (WWTPs ...
Helena Rapp‐Wright, Keng Tiong Ng, Derryn Grant, William Francis, Margarita White, Dimitris Evangelopoulos, Yuxing Liu, Konstantina Dimakopoulou, Sofia Zafeiratou, Dylan Wood, Chryshanthi Christy, Stav Friedman, Timothy W. Gant, Klea Katsouyanni, Leon P. Barron   +14 more
wiley   +1 more source

Alcohol and alcoholism

BMJ, 1982
openaire   +4 more sources

Association between fibrinogen concentration and nonunion in fracture patients. [PDF]

Front Surg
Geng L, Wang Z, Dong J, Lu B, Wang J, Wang Y, Liu Y.   +6 more
europepmc   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

Addiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka, Francesca Spiga, Tom P. Freeman, Suzanne Nielsen, Jelena Savović, Julian P. T. Higgins, Deborah M. Caldwell   +6 more
wiley   +1 more source

CYP2C19 intermediate and poor metabolizer statuses may be associated with coronary atherosclerosis among patients with type 2 diabetes mellitus. [PDF]

Front Med (Lausanne)
Cai N, Li Y, Liu J, Huang C, Hong H, Li H, Peng J.   +6 more
europepmc   +1 more source

The association between sleep disturbance and stimulant use: A cross‐lagged examination

Addiction, EarlyView.
Abstract Background and aims Sleep disruptions increase the risk of substance misuse. Substance use—especially stimulants—can increase acute and chronic sleep dysfunction. This study aimed to estimate the associations between sleep disturbance and stimulant use over time among participants with stimulant use disorder (StUD).
Viviana E. Horigian, Renae D. Schmidt, Daniel J. Feaster, Rui Duan, Sophia T. Gonzalez, Kathryn Hefner, Dikla Shmueli‐Blumberg, Ashley Vena, Landhing M. Moran, Chloe A. DiCamillo, Shirin Shafazand, Susan Tross, Judith Feinberg   +12 more
wiley   +1 more source

Risk Factors Disrupting Wholistic Wellness Among Indigenous Families During COVID-19. [PDF]

Fam Process
Locklear K, Ka'apu K, O'Connor CE, Johnson-Jennings M, Rau J.   +4 more
europepmc   +1 more source